Vaxneuvance 0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FTEHW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,879
Award facts
- Contract value 100% obligated
- $10,878.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,878.67 to AmerisourceBergen Drug Corp for Vaxneuvance 0.5 ML syringes on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a prime IDV valued at $999,999,999.00 running through December 2026 that enables supply of a comprehensive range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related medical commodities globally.
Vaxneuvance is a pneumococcal vaccine used to prevent pneumococcal disease, and this delivery order supports the Defense Health Agency and other government healthcare systems' immunization requirements. The award demonstrates AmerisourceBergen's established capability to meet federal procurement requirements through open competition and reflects the company's significant role in supplying critical vaccines and pharmaceutical products to the Department of Defense medical supply chain. The contract's firm fixed pricing structure and rapid delivery timeline underscore the company's operational efficiency in fulfilling urgent federal medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FTEHW?
SPE2DB25FTEHW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FTEHW worth?
The government has obligated $10,879 on SPE2DB25FTEHW.
Is contract SPE2DB25FTEHW an order under another contract?
Yes. SPE2DB25FTEHW is a delivery order under SPE2DB25D3110, an indefinite delivery contract.
Was contract SPE2DB25FTEHW competed?
The extent of competition for SPE2DB25FTEHW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award